3-((Dimethylamino)Methyl)-N,N-Dimethylaniline
Product Type
Impurity Standards
CAT. No.
MRL-R18029
CAS. No.
179676-15-4
Mol. F.
C11H18N2
Mol. Wt.
178.27
Synonyms
NA
Chemical Name
3-((Dimethylamino)methyl)-N,N-dimethylaniline
Stock Status
3-((Dimethylamino)Methyl)-N,N-Dimethylaniline with CAS No: 179676-15-4 is an impurity standard of Rivastigmine. Rivastigmine is a medication used in the treatment of Alzheimers disease and Parkinsons disease-related dementia. Structurally, it is a carbamate derivative. Rivastigmine belongs to the class of acetylcholinesterase inhibitors, and its primary mechanism of action involves increasing levels of acetylcholine, a neurotransmitter involved in cognitive function, by inhibiting its breakdown. This is particularly beneficial in conditions where there is a deficiency of acetylcholine, as seen in Alzheimers and Parkinsons disease-related dementia. Rivastigmine is available in various formulations, including oral capsules and transdermal patches, allowing for flexibility in administration. Buy high quality 3-((Dimethylamino)Methyl)-N,N-Dimethylaniline from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of 3-((Dimethylamino)Methyl)-N,N-Dimethylaniline